bluebird bio Enters Lentiviral Vector Patent License Agreement with GSK for Commercialization of Gene Therapies Read more
bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies Read more
Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic Read more
Atlantic Healthcare initiates FDA rolling submission of its New Drug Application for alicaforsen in the treatment of pouchitis Read more
Sunesis Pharmaceuticals Announces Withdrawal of European MAA for Vosaroxin as a Treatment for Relapsed/Refractory AML Read more
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer’s Disease Read more
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD Read more